ARCHIVED POPULATION DATA
Other Tumors of Brain and ONS
Archived November 2024 SEER release. This is relative survival from diagnosis for the published population, not an individual prediction or a treatment-effect estimate.
Relative survival across follow-up
| Year | Relative survival (%) | 95% CI lower | 95% CI upper | Standard error | Cases |
|---|---|---|---|---|---|
| 0 | 100 | Not published | Not published | Not published | 9154 |
| 1 | 53.5685 | 52.5131 | 54.6116 | 0.5354 | 9154 |
| 2 | 49.0841 | 48.0141 | 50.1446 | 0.5436 | 9154 |
| 3 | 46.2873 | 45.2074 | 47.3596 | 0.5491 | 9154 |
| 4 | 44.496 | 43.4066 | 45.5792 | 0.5543 | 9154 |
| 5 | 43.4174 | 42.3174 | 44.5119 | 0.5599 | 9154 |
| 6 | 42.2124 | 41.1009 | 43.3193 | 0.566 | 9154 |
| 7 | 40.8502 | 39.7256 | 41.9712 | 0.573 | 9154 |
| 8 | 39.838 | 38.699 | 40.9741 | 0.5805 | 9154 |
| 9 | 39.0295 | 37.8749 | 40.182 | 0.5886 | 9154 |
| 10 | 38.3657 | 37.1939 | 39.5359 | 0.5976 | 9154 |
Source definitions, footnotes and provenance
- age and race caveat
- Published age/race categories can overlap. They are selectable strata, not partitions to add together.
- cohort count definition
- Source Number of Cases, repeated by follow-up row; not people remaining at risk.
- content sha256
- 068cde2334981c62302dd91f68a6dcbe112fd6ea0fe3d9d290fa63f0cbb3dadf
- dimensions
- Age at Diagnosis
- Ages 15-39
- Ages 40-64
- Ages 50-64
- Ages 65+
- Ages 65-74
- Ages 75+
- Ages < 15
- Ages < 20
- Ages < 50
- All Ages
- Race/Ethnicity
- All Races / Ethnicities
- Black (includes Hispanic)
- Hispanic (any race)
- Non-Hispanic American Indian / Alaska Native
- Non-Hispanic Asian / Pacific Islander
- Non-Hispanic Black
- Non-Hispanic White
- White (includes Hispanic)
- Sex
- Both Sexes
- Female
- Male
- Stage at Diagnosis
- All Stages
- Distant
- Localized
- Regional
- Unstaged
- Years of Diagnosis
- 2000-2021
- id
- brain-ons-other-tumors
- immutable id
- seer-group:brain-ons-other-tumors@068cde2334981c62302dd91f68a6dcbe112fd6ea0fe3d9d290fa63f0cbb3dadf
- method
- Relative survival calculated using monthly intervals; table publishes annual landmarks from diagnosis through year ten.
- missing value definition
- Source dash (-) does not differentiate suppression, unavailable data, or other missingness. No suppression reason is inferred.
- normalized source
- file
- normalized/followup/brain-ons-other-tumors.json.gz
- sha256
- f8d8febe78540fc7f63f9ef6273b6b45be7eab29fbb12c293a8bfcc936e90755
- period interpretation
- The displayed diagnosis period is the source table label. Exact case-eligible years are not inferred from it.
- registry
- SEER 21 (excluding Illinois)
- sheet
- Brain & ONS, Other Tumors
- site
- Other Tumors of Brain and ONS
- source
- bytes
- 45275886
- file
- raw/Survival by Survival Time, November 2024.xlsx
- retrieved at
- 2026-09-09T23:23:39.141323+00:00
- sha256
- 4300662c48518fc384f68c039c8bbcd2a072e603576b36d327e6b17f80771e34
- title
- Survival by Survival Time
- source footnotes
- row
- 13208
- values
- Footnotes
- row
- 13209
- values
- Data Source:
- row
- 13210
- values
- -SEER Incidence Data, November 2024 Submission (1975-2022), SEER 21 registries [https://seer.cancer.gov/registries/terms.html] (excluding Illinois).
- row
- 13211
- values
- -Expected Survival Life Tables [https://seer.cancer.gov/expsurvival/] by Socio-Economic Standards.
- row
- 13212
- values
- Methodology:
- row
- 13213
- values
- -The relative survival rates are calculated using monthly intervals.
- row
- 13214
- values
- Race/Ethnicity Coding:
- row
- 13215
- values
- -For more details on SEER race/ethnicity groupings, please see Race and Hispanic Ethnicity Changes [https://seer.cancer.gov/seerstat/variables/seer/race_ethnicity/].
- row
- 13216
- values
- -Incidence data for Hispanics and Non-Hispanics are based on the NAACCR Hispanic Latino Identification Algorithm (NHIA).
- row
- 13217
- values
- -Rates for American Indians/Alaska Natives only include cases that are in a Purchased/Referred Care Delivery Area (PRCDA).
- row
- 13218
- values
- Cancer Site Coding:
- row
- 13219
- values
- -See SEER*Explorer Cancer Site Definitions [https://seer.cancer.gov/statistics-network/explorer/cancer-sites.html] for details about the cancer site coding used for SEER Incidence data.
- source header rows
- SEER Explorer Data Archive, November 2024 SEER Submission (April 2025 Release)
- Other Tumors of Brain and ONS
- SEER Relative Survival Rates by Time Since Diagnosis
- source missing marker
- -
- stage coding footnotes
- row
- 13220
- values
- -Stage at diagnosis is calculated using the Combined Summary Stage (2004+) recode, created from SEER Combined Summary Stage 2000 (2004-2017) & Derived Summary Stage 2018 (2018+). For more information, see the SEER documentation[https://seer.cancer.gov/seerstat/variables/seer/lrd-stage].
- stage period caveat
- Combined Summary Stage (2004+) uses coding starting in 2004; the 2000-2021 label must not be read as full stage-specific coverage from 2000.
- stage system
- Combined Summary Stage (2004+)
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle